2026. Machine Learning-Driven Pharmacovigilance Models for Drug-Induced Liver Injury (DILI) Risk Prediction and Personalized Therapeutic Dose Optimization in Chronic Liver Disease Patients. The Science Post. 2, 3 (Aug. 2026).